Newsroom
Key Players Set to Present at Morgan Stanley's Global Healthcare Conference
By KlickAnalytics Data Insights | August 31, 2026 08:04PM ET
Key Points
- Sarepta Therapeutics, SI-BONE, Vir Biotechnology, IDEXX Laboratories, Kalaris Therapeutics, and OnKure Therapeutics will all participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026.
- Each company's senior management will host fireside chats to discuss their respective developments and innovations in the healthcare sector.
- Presentations will be webcast live on the companies' websites and archived for future viewing.
- Topics of discussion will include precision genetic medicine for rare diseases, procedural solutions for compromised bone, drug development for prevalent retinal diseases, and pet healthcare innovation.
- The conference aims to showcase the latest advancements and opportunities in the healthcare industry.
Several leading healthcare companies are gearing up to participate in the highly anticipated Morgan Stanley 24th Annual Global Healthcare Conference scheduled to take place on Monday, September 14, 2026. Sarepta Therapeutics, Inc., a pioneer in precision genetic medicine for rare diseases, will have its senior management engage in a fireside chat at 8:30 a.m. ET during the event. Interested parties can tune in to the live webcast on Sarepta's investor relations section of the website and access the archived presentation later on.
Joining Sarepta Therapeutics at the conference is SI-BONE, Inc., the global leader in developing procedural solutions for clinical challenges related to compromised bone. The company will also host a fireside chat on the same day at 8:30 a.m. Pacific Time/11:30 a.m. Eastern Time, discussing its innovative solutions in the healthcare industry. Similarly, Vir Biotechnology, Inc. will be represented by Marianne De Backer, the President and Chief Executive Officer, in a fireside chat scheduled for 7:45 a.m. ET. The live webcast of this session will be available on the company's website, providing insights into the latest advancements in drug development.
Furthermore, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will feature Mike Erickson, the President and Chief Executive Officer, and Andrew Emerson, the Executive Vice President and Chief Financial Officer, in a fireside chat from 10:45 a.m. to 11:20 a.m. ET. The interactive session will delve into IDEXX's contributions to pet healthcare and its ongoing efforts to drive innovation in the field. Kalaris Therapeutics, Inc., a biopharmaceutical company dedicated to treating prevalent retinal diseases, will also be present at the conference to discuss its novel treatments, including the development of TH103 for neovascular Age-related Macular Degeneration (nAMD).
Lastly, OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in precision medicines, will participate in the conference to showcase its cutting-edge developments in the healthcare sector. The conference presents an exciting opportunity for stakeholders to engage with industry leaders, gain valuable insights into the latest trends, and explore potential collaborations. As these key players take the stage at the Morgan Stanley event, the healthcare community eagerly anticipates the valuable discussions and insights that will emerge from these presentations.
For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with